CORE

🇺🇦   make metadata, not war

    3 research outputs found

    Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia

    Author
    Publication venue
    'Ferrata Storti Foundation (Haematologica)'
    Publication date
    Field of study
    Get PDF
    Crossref
    Online Research @ Cardiff
    Directory of Open Access Journals

    Long-term relapse-free survival in a phase 2 study of blinatumomab for the treatment of patients with minimal residual disease in B-lineage acute lymphoblastic leukemia

    Author
    Publication venue
    'Ferrata Storti Foundation (Haematologica)'
    Publication date
    Field of study
    Full text link
    Crossref

    Phase II Trial of the Anti-CD19 Bispecific T Cell–Engager Blinatumomab Shows Hematologic and Molecular Remissions in Patients With Relapsed or Refractory B-Precursor Acute Lymphoblastic Leukemia

    Author
    Publication venue
    'American Society of Clinical Oncology (ASCO)'
    Publication date
    Field of study
    Full text link
    Crossref
    corecore